International Urology and Nephrology

, Volume 45, Issue 5, pp 1245–1251 | Cite as

Clinical outcomes of augmentation cystoplasty in patients suffering from ketamine-related bladder contractures

  • Chi-Fai Ng
  • Peter K. F. Chiu
  • Miu-Ling Li
  • Chi-Wai Man
  • Simon S. M. Hou
  • Eddie S. Y. Chan
  • Peggy S. K. Chu
Urology - Original Paper



To evaluate the outcomes of augmentation cystoplasty in patients with bladder contractures secondary to chronic ketamine abuse.


Patients who had received augmentation cystoplasty to treat ketamine-related bladder contractures in two hospitals in our region were reviewed retrospectively. Their history of ketamine consumption, presenting symptoms, history of treatment, surgical information and post-operative conditions were retrieved from clinical records and then summarized.


Between 2006 and 2011, four patients (three women and one man), aged 21–30 years (mean 27 years), underwent augmentation cystoplasty for ketamine-related bladder contractures. The duration of ketamine consumption ranged from 3 to 15 years, and all four patients resumed ketamine consumption after surgery. The mean maximal baseline and post-operative bladder capacity was 37.5 cc (range 25–50 cc) and up to 400–500 cc, respectively. Three patients experienced a further deterioration in renal function that was secondary to new-onset ureteral strictures in two cases and to sepsis in the other. At the time of the last follow-up, three patients could void spontaneously and one required regular intermittent catheterization.


Ketamine cystitis is an emerging medical condition that requires a multi-disciplinary approach to manage the patients. Simple surgical management of the physical component of the contracted bladder may produce only suboptimal results, and could even cause further problems in some patients. The importance of compliance with post-operative care and abstinence from drug use should be stressed to the patients before surgery. In view of the high complication rate, the option of a simple ileal conduit should also be discussed prior to surgical intervention.


Ketamine cystitis Bladder augmentation Enterocystoplasty Overactive bladder Complications 


Conflict of interest



  1. 1.
    Kalsi SS, Wood DM, Dargan PI (2011) The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J 4:7107–7116Google Scholar
  2. 2.
    Wolff K (2012) Ketamine. In: Verster JC et al (eds) Drug abuse and addiction in medical illness: causes, consequences and treatment. Springer, New York, pp 201–211CrossRefGoogle Scholar
  3. 3.
    Froster JA, Harrison SCW (2012) Ketamine uropathy: rising to the challenges of a new condition. BJU Int 109:1277–1278CrossRefGoogle Scholar
  4. 4.
    Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM (2012) The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int 110:1762–1766PubMedCrossRefGoogle Scholar
  5. 5.
    Lin M (2004) The underappreciated dangers of “club drugs”: what clinicians need to know. Adv Stud Med 4:191–198Google Scholar
  6. 6.
    Shahani R, Streutker C, Dickson B, Stewart RJ (2007) Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69:810–812PubMedCrossRefGoogle Scholar
  7. 7.
    Chu PS, Kwok SC, Lam KM, Chu TY, Chan SW, Man CW, Ma WK, Chui KL, Yiu MK, Chan YC, Tse ML, Lau FL (2007) ‘Street ketamine’-associated bladder dysfunction: a report of ten cases. Hong Kong Med J 13:311–313PubMedGoogle Scholar
  8. 8.
    Middela S, Pearce I (2011) Ketamine-induced vesiculopathy: a literature review. Int J Clin Pract 65:27–30PubMedCrossRefGoogle Scholar
  9. 9.
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMedCrossRefGoogle Scholar
  10. 10.
    Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S, Tse JML, Lau FL, Yiu MK, Man CW (2008) The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int 102:1616–1622PubMedCrossRefGoogle Scholar
  11. 11.
    Biers SM, Venn SN, Greenwell TJ (2012) The past, present and future of augmentation cystoplasty. BJU Int 109:1280–1293PubMedCrossRefGoogle Scholar
  12. 12.
    Stein R, Schröder A, Thüroff JW (2012) Bladder augmentation and urinary diversion in patients with neurogenic bladder: surgical considerations. J Pediatr Urol 8:153–161PubMedCrossRefGoogle Scholar
  13. 13.
    Stein R, Kamal MM, Rubenwolf P, Ziesel C, Schröder A, Thüroff JW (2012) Bladder augmentation using bowel segments (enterocystoplasty). BJU Int 110:1078–1094PubMedCrossRefGoogle Scholar
  14. 14.
    Craven R (2007) Ketamine. Anaesthesia 62(Suppl 1):48–53PubMedCrossRefGoogle Scholar
  15. 15.
    Adamowicz P, Kala M (2005) Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations. J Anal Toxicol 29:376–382PubMedCrossRefGoogle Scholar
  16. 16.
    Blonk MI, Koder BG, van den Bemt PM, Huygen FJ (2010) Use of oral ketamine in chronic pain management: a review. Eur J Pain 14:466–472PubMedCrossRefGoogle Scholar
  17. 17.
    Greenwell TJ, Venn SN, Mundy AR (2001) Augmentation cystoplasty. BJU Int 88:511–525PubMedCrossRefGoogle Scholar
  18. 18.
    DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107PubMedCrossRefGoogle Scholar
  19. 19.
    Tabor PA, Lopez DA (2004) Comply with us: improving medication adherence. J Pharm Pract 17:167–180CrossRefGoogle Scholar
  20. 20.
    Lucas GM (2011) Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. Life Sci 88:948–952PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Chi-Fai Ng
    • 1
  • Peter K. F. Chiu
    • 1
  • Miu-Ling Li
    • 2
  • Chi-Wai Man
    • 2
  • Simon S. M. Hou
    • 1
  • Eddie S. Y. Chan
    • 1
  • Peggy S. K. Chu
    • 2
  1. 1.Division of Urology, Department of SurgeryThe Chinese University of Hong KongHong Kong, SARChina
  2. 2.Department of SurgeryTuen Mun HospitalTuen Mun, Hong KongChina

Personalised recommendations